Wako, Japan

Toshitada Takemori



Average Co-Inventor Count = 6.9

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Toshitada Takemori

Introduction: Toshitada Takemori, an accomplished inventor based in Wako, Japan, has made significant strides in the field of biomedicine. With two patents to his name, his work primarily focuses on the development of novel antibodies aimed at combating cancer and advancing therapeutic options for patients.

Latest Patents: Takemori's latest innovations include the invention of an Anti-Eva1 protein antibody. This invention was designed to provide an antibody with high therapeutic and prophylactic effects against cancer. It involves the preparation of three types of mouse monoclonal antibodies that exhibit high affinities for a human-derived Eva1 protein. By substituting the constant regions of these antibodies with human-derived constant regions, Takemori successfully prepared chimeric antibodies, which demonstrated high ADCC and/or CDC activities. Furthermore, these antibodies showed promise in suppressing melanoma cell metastasis when administered to mice.

Another notable patent from Takemori is the isolated monoclonal antibody against human Transforming Growth Factor-β (TGF-β) Latency Associated Protein (LAP) degradate. This antibody is capable of recognizing an integrin binding site within the human TGF-β LAP degradate, marking a significant advancement in understanding and targeting the TGF-β pathway.

Career Highlights: Toshitada Takemori has collaborated with esteemed institutions, including the National University Corporation Hokkaido University and Riken Corporation. His career is marked by a commitment to advancing biotechnological innovations through rigorous research and development.

Collaborations: In his journey, Takemori has worked alongside talented coworkers such as Mikako Shirouzu and Miho Tanaka. Their joint efforts have contributed to the successful realization of his innovative ideas and patents.

Conclusion: Toshitada Takemori exemplifies the spirit of innovation within the biomedical field. With his groundbreaking work on antibodies targeting cancer-related proteins, he continues to pave the way for new therapeutic strategies. The impact of his inventions underscores the importance of collaboration and creativity in advancing science and healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…